For women over 50, weight loss isn't just about shedding pounds; it's about preserving muscle mass, boosting metabolism, and reducing the risk of chronic diseases like heart disease and diabetes ...

Pharmacy benefit manager CVS Caremark drops Zepbound coverage, estimating 10-15% savings while Eli Lilly offers self-pay ...

A large network meta-analysis ranked eight GLP-1 receptor agonists for glycemic, weight, and safety outcomes in adults with ...

Business Insider spoke to Eli Lilly's new president of cardiometabolic health, who shared the company's aggressive incretin ...

MariTide helped participants lose up to 20% of their body weight in a year-long trial. But it could be years before the new ...

While most of us are familiar with type 1, type 2, and even gestational diabetes, there are actually six kinds of diabetes ...

Type 2 diabetes remission and weight loss rates are significantly higher among adults who replace diet beverages with water.

The treatment led to an average 20 per cent weight loss in people living with obesity alone and a nearly 17 per cent mean weight loss in those living with obesity and type 2 diabetes, the study found.

Objective This study aimed to assess dietary practice and associated factors among patients with diabetes attending the Debre Tabor General Hospital. Design Institutional-based cross-sectional study.

Researchers at the Case Western Reserve School of Medicine have found that semaglutide, a popular diabetes and weight-loss drug, may lower the risk of dementia in people with type 2 diabetes (T2D ...

A new study involving nearly 1.7 million patients suggests that semaglutide — a drug that mimics a gut hormone to lower blood sugar and aid weight loss — could significantly cut dementia risk ...